151 related articles for article (PubMed ID: 31746987)
1. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
[TBL] [Abstract][Full Text] [Related]
2. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
[TBL] [Abstract][Full Text] [Related]
3. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of the tumor volume doubling time in clinical T1 non-small cell lung cancer with solid radiological findings.
Nakahashi K; Shiono S; Nakatsuka M; Endo M
J Surg Oncol; 2022 Dec; 126(7):1330-1340. PubMed ID: 35921201
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
[TBL] [Abstract][Full Text] [Related]
6. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
Liu M; Mu J; Song F; Liu X; Jing W; Lv F
Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
[TBL] [Abstract][Full Text] [Related]
8. Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.
Li Z; Pan C; Xu W; Zhao C; Pan X; Wang Z; Wu W; Chen L
Respir Res; 2024 Feb; 25(1):96. PubMed ID: 38383329
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non-Small Cell Lung Cancer.
Takenaka T; Yamazaki K; Miura N; Mori R; Takeo S
J Thorac Oncol; 2016 Jul; 11(7):1074-80. PubMed ID: 26899756
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Ito H; Nakayama H; Ikeda N; Okada M
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1245-1253. PubMed ID: 32893296
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
13. Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.
Park S; Lee SM; Kim S; Lee JG; Choi S; Do KH; Seo JB
Radiology; 2020 Jun; 295(3):703-712. PubMed ID: 32228296
[TBL] [Abstract][Full Text] [Related]
14. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
15. Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.
Domachevsky L; Groshar D; Galili R; Saute M; Bernstine H
Eur Radiol; 2015 Nov; 25(11):3361-7. PubMed ID: 25929940
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of part-solid lung cancer in the eighth edition TNM staging system.
Okamoto T; Miyawaki M; Toyokawa G; Karashima T; Abe M; Takumi Y; Hashimoto T; Osoegawa A; Tagawa T; Takeuchi H; Shimokawa M; Sugio K
Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):219-226. PubMed ID: 34561707
[TBL] [Abstract][Full Text] [Related]
18. The progression of non-small cell lung cancer from diagnosis to surgery.
McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
[TBL] [Abstract][Full Text] [Related]
19. Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.
Huang CS; Chien HC; Chen CK; Yeh YC; Hsu PK; Chen HS; Hsieh CC; Hsu HS; Huang BS; Shih CC
Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):537-545. PubMed ID: 33332546
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
Ohtaki Y; Shimizu K; Kaira K; Nagashima T; Obayashi K; Nakazawa S; Kakegawa S; Igai H; Kamiyoshihara M; Nishiyama M; Takeyoshi I
Surg Today; 2016 Oct; 46(10):1196-208. PubMed ID: 26782692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
